Vytalyou: Using AI and Preventive Medicine to Redefine Longevity Healthcare

November 13, 2026 | Friday | Features

Moving healthcare beyond disease management towards early risk identification and healthy ageing, Vytalyou is building a doctor-led preventive longevity ecosystem. Founded by specialists in molecular oncology and radiology, the Mumbai-based venture combines advanced diagnostics, AI-guided health assessments and personalised wellness interventions to help individuals make more informed decisions about their long-term health.

Problem

Conventional health check-ups often focus on identifying existing conditions rather than understanding early indicators of biological ageing and future health risks. Vytalyou aims to address this gap through integrated diagnostics and personalised preventive health assessments.

Product

Its core offering is the Predictive Longevity Evaluation, which brings together blood investigations, radiology, genomics, cardiovascular assessments and body-composition analysis. An AI-guided platform analyses health data to generate insights on biological age, metabolic health and potential risk areas, which doctors use to develop personalised wellness plans.

Proof

Vytalyou operates a doctor-supervised longevity centre in Powai, Mumbai, offering diagnostics, physician consultations and personalised IV wellness programmes. Its service portfolio also includes home-based IV therapy and sample collection, while several advanced modalities, including regenerative cell therapy and red-light therapy, are listed as upcoming services.

People

Founded by Dr. Chirantan Bose, a molecular oncologist, and Dr. Preetesh Bhandari, a radiologist, Vytalyou brings together expertise in molecular diagnostics, genomics, medical imaging and preventive healthcare. The founders lead the company's efforts to integrate clinical expertise with technology-led longevity services.

Purse

Vytalyou raised approximately ₹9 crore in a pre-Series A funding round in August 2026, at a reported valuation of around ₹33 crore. The investment came from Chetan Jain of Pharma Dose and Ratan Jain of Venus Industries to support its clinic expansion plans.

Plan

The company plans to expand its Mumbai presence from its existing Powai centre to three locations, with new centres planned in Juhu and Worli. It is also targeting expansion into other major Indian cities in 2027, with a longer-term ambition to build a network of 10 clinics across India.

Why it matters

Preventive healthcare is increasingly shifting towards early risk detection, personalised interventions and long-term health management. By bringing diagnostics, AI-guided assessments and physician-supervised wellness services together, Vytalyou is exploring an integrated model for India's emerging longevity healthcare market.

FAST FACTS

Particulars

Details

Company

CBPB Diagnostic Services Private Limited

Brand

Vytalyou

Inception

September 2025

Headquarters

Mumbai, Maharashtra

Industry

Preventive Healthcare, Longevity Science, Medical Diagnostics

Founders

Dr. Chirantan Bose and Dr. Preetesh Bhandari

Core Offering

Predictive Longevity Evaluation

Key Services

Diagnostics, Genomics, Body Composition Analysis, IV Therapy

Technology

AI-guided health and longevity assessment

Funding

Approximately ₹9 crore

Funding Stage

Pre-Series A

Investors

Chetan Jain (Pharma Dose) and Ratan Jain (Venus Industries)

Reported Valuation

Approximately ₹33 crore

Website

vytalyou.com

 Disclaimer: This profile is based on publicly available company information. 

Comments

× Your session has expired. Please click here to Sign-in or Sign-up

Have an Account?

OR

Forgot your password?

OR

First Name should not be empty!

Last Name should not be empty!

Email address should not be empty!

Show Password should not be empty!

Show Confirm Password should not be empty!

Newsletter

E-magazine

Biospectrum Infomercial

Bio Resource

I accept the terms & conditions & Privacy policy